Tea Party’s Joe Walsh Calls ‘Bullsh*t’ on Trump

New Post Public Reply Private Reply Replies (0) Message Board
Bhawks
Quote:
Tea Party’s Joe Walsh Calls ‘Bullsh*t’ on Trump Decision to Hire Goldman Sachs Execs

By Hrafnkell Haraldsson on Fri, Dec 2nd, 2016 at 8:58 am

"Mr Trump, this is bullshit. Can you hire someone who doesn't work for Goldman Sachs? What about that swamp? Huh? "

Joe-Walsh2.jpg

Tea Party deadbeat dad and professional crybaby Joe Walsh, who once threatened armed rebellion if Trump lost, is a bit upset with his hero’s decision to hire Goldman Sachs’ Steven Mnuchin as Treasury Secretary and his consideration of Goldman Sachs Group President and Chief Operating Officer Gary Cohn for energy secretary.

As Politico warns, Goldman Sachs is “poised for return to power” in a Trump administration. Walsh duly tweeted,

“Mr Trump, this is bullshit. Can you hire someone who doesn’t work for Goldman Sachs? What about that swamp? Huh?”

Joe Walsh Verified account 
‏@WalshFreedom
Mr Trump, this is bullshit. Can you hire someone who doesn't work for Goldman Sachs?

What about that swamp? Huh?

Just to make his point clear, in between bizarre tweets about penises and his sister and cakes for gays, Walsh tweeted

Joe Walsh
✔ ‎@WalshFreedom

So far he's not draining the swamp. It's a cabinet full of wealthy insiders.

Come on Donald. It wasn't a corny phrase. It got you elected

Apparently, it is not only the media that, as Corey Lewandowski accused, took Trump too literally. “The American people didn’t,” Lewandowski insisted. “They understood it.” Well…excluding Walsh.

More remarkably, however, this is an actual incidence of Joe Walsh having an actual, verifiable reason to complain about something. And more remarkable still, he’s actually right.

Well…except for the penis thing.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

InsCorp's Steady Q3 Climb Mirrors Strategic Focus

Updated Category News Views 46

Riding the Revenue Wave Now we're talking about a bank knowing their business—InsCorp, Inc. recently flaunted a 12% year-on-year revenue bump for 3Q26, a testament to a strategy that's clearly sticking. Still, while those numbers are nice and shiny, the detailed breakdown shows earnings per share (EPS) barely budged from last quarter, coming in at $0.73, just a hair...

Continue Reading
Nanoscope Therapeutics Aims for Eye-Catching Advances

Updated Category News Views 87

Gearing Up for a Boston Showcase Nanoscope's High-Stakes Boston Rendezvous In a move set to grab some serious eyeballs, Nanoscope Therapeutics is geared up to strut their stuff at Advanced Therapies USA 2026 in Boston. Scheduled for November 4–5 at the Hynes Convention Center, the event isn't just another pitstop—it's a billboard for what these guys have cooking. With...

Continue Reading
Kuvings Unveils Hands-Free Juicer for Healthy Living

Updated Category News Views 96

A Fresh Squeeze in the Juice World If you've ever wanted something that makes that morning juice without you running a marathon in your own kitchen, Kuvings might just have the answer with their new AUTO10 SQUARE™ Plus. Announced on October 30, 2026, this isn't just another fancy named gadget—it actually shakes things up with a hands-free design that’s tailored for...

Continue Reading
CMRE Facing Legal Heat Over Wage Allegations

Updated Category News Views 10

Another Day, Another Lawsuit Ah, work. It’s what gets us up in the morning, whether we like it or not. Yet, for many, it can feel more like a dubious hustle when the rewards don't match the effort. Now, CMRE Financial Services, Inc. finds itself under the legal microscope, thanks to a fresh class-action lawsuit filed by the legal eagles at Blumenthal Nordrehaug Bhowmik...

Continue Reading
Lepage Millwork to Acquire Custom Window Maker Fenêtres MQ

Updated Category News Views 64

Big Move in Windows: Lepage Eyes Fenêtres MQ Dust off those old window ledgers, folks, because we've got a shake-up in the custom luxury window game. Lepage Millwork, a family-run titan in the North American fenestration scene, is gearing up to take over Fenêtres MQ from the big shots over at Andersen. We're talking about an ownership shift set to seal the deal by...

Continue Reading
Bybit Unveils Platform Vision at HK FinTech Week

Updated Category News Views 63

Bybit's Strategic Participation at HK FinTech Week Here’s what’s got everyone buzzing: Bybit is stepping onto the big stage at the Hong Kong FinTech Week 2026. We're talking about the crème de la crème of fintech gatherings, where the sharpest minds of the financial world mingle, munch, and strategize under the buzzing neon of Hong Kong. Bybit's involvement is no...

Continue Reading
WHI's Nexus AI Transforms Phone Ordering in Parts Biz

Updated Category News Views 174

Nexus AI: The New Frontline for Part Distributors In a move poised to shake up the auto parts distribution scene, WHI Solutions, a child of eBay, is rolling out a game-changer: the Nexus AI suite designed for the Nexpart platform. Now, tech and tradition blend as AI tackles phone ordering for those early-morning rushes and late-night calls. A Solution for Your Busiest...

Continue Reading
Texas Home Boasts PGA-Caliber Green with Synthetic Turf

Updated Category News Views 40

Swinging for Luxury in Your Backyard Who'd have thought that a chunk of Austin, Texas, could boast a putting green that’s giving any PGA course a run for its money? We’re talking about a family here who decided they’d had enough of scalding summers and winter chills and wanted a taste of that country club glam at home without the upkeep headaches. The Rise of...

Continue Reading
California Housing Affordability Stagnant as Rates Rise

Updated Category News Views 55

Numbers Tell the Story Get this: California's housing market's as sticky as day-old gum on a hot sidewalk. Despite a dip in home prices, affordability just won't budge. The California Association of REALTORS® (C.A.R.) says 19% of households could afford a median-priced home at $894,630, exactly like last quarter and even a year back. Not a flicker of change. Quirky it...

Continue Reading
Endava's Securities Class Action Heats Up Wall Street

Updated Category News Views 13

A Head-Spinning Fall for Endava Endava's recent tumble on the NYSE has investors rubbing their eyes in disbelief. A jaw-dropping 25% slide in share value on September 22, 2026, has everyone scrambling for answers. Looks like some serious skeletons were hiding deep in Endava's closets—management snafus and fuzzy accounting being at the forefront. This debacle has peeled...

Continue Reading

Top 5 Most Recently Viewed Articles

Amendments Approved by Baltic Horizon Fund Bondholders

Updated Category News Views 192

Key Amendments Approved for Baltic Horizon Fund Bonds Baltic Horizon Fund sought the approval of its bondholders for several amendments related to its EUR 42 million floating rate bonds set to mature in 2028. This written procedure occurred recently, allowing bondholders to engage in crucial decisions regarding the terms governing their investments. Voting Procedures and...

Continue Reading
Sagimet Biosciences Shares Exciting First Quarter Highlights

Updated Category News Views 177

Sagimet Biosciences Financial Overview Sagimet Biosciences Inc. (NASDAQ: SGMT), a pioneering clinical-stage biopharmaceutical company, has made waves in the healthcare industry with its innovative approach to combating metabolic dysfunction and fibrotic diseases. Recently, this California-based firm announced their financial results for the first quarter, concluding on...

Continue Reading
Important Class Action for Lilium N.V. Shareholders to Join

Updated Category News Views 107

Class Action Notice for Shareholders of Lilium N.V. (LILMF) The Gross Law Firm has announced a significant action that involves shareholders of Lilium N.V. (LILMF). This notice is particularly important for those who have purchased shares during the specified class period. If you have invested in Lilium, it is crucial to understand the implications of this class action....

Continue Reading
Intellia Launches Pivotal Phase 3 Trial for NTLA-2002

Updated Category News Views 84

Intellia Therapeutics Advances Gene Editing with NTLA-2002 Intellia Therapeutics, Inc. (NASDAQ: NTLA), an innovator in CRISPR-based gene editing therapies, has announced the launch of a pivotal Phase 3 trial for its revolutionary treatment NTLA-2002. This therapy is aimed at addressing hereditary angioedema (HAE), a rare but severe condition that can lead to...

Continue Reading
Margot Black Unveils New Book: Transform Your Dreams Now

Updated Category News Views 120

Margot Black Announces Her Empowering New Book Margot Black's latest guide offers a roadmap for dreamers to achieve real-life results Award-winning publicist, communication strategist, and bestselling author Margot Black is set to inspire readers with her third book, How to Be Your Own Fairy Godmother and Make Your Life Come True. This innovative guide is crafted to...

Continue Reading